Product Information
EFAVIRENZ 600 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.3491 per EA under NDC 65862004930. Its NADAC has been published 275 times since Oct 14, 2020.
FDA first approved this application on Sep 21, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862004930
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EFAVIRENZApproval Type
Generic (ANDA)
FDA Application
ANDA077673FDA Approved
9/21/2018
TE Code
AB
On Market Since
9/21/2018
Pharmacological Classes
Price Statistics
The NADAC for EFAVIRENZ 600 MG TABLET has been published 275 times since Oct 14, 2020, and over the history we have for it it has declined 85.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3491 per EA |
|---|---|
| All-time high | $9.0741 (Dec 16, 2020) |
| All-time low | $1.3206 (Feb 19, 2025) |
| 52-week high | $1.7446 |
| 52-week low | $1.3491 |
| Median price | $2.7606 |
| Average price | $3.4821 |
| Largest weekly change | -43.3% (Mar 22, 2023) |
| Weeks tracked | 275 |
| Tracking since | Oct 14, 2020 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EFAVIRENZ 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ 600 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.3491 per EA (NDC 65862004930), effective Aug 19, 2026.
How has the price of EFAVIRENZ 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for EFAVIRENZ 600 MG TABLET has declined 85.1%. It has been tracked across 275 weekly CMS publications since Oct 14, 2020.
What are the highest and lowest recorded NADAC prices for EFAVIRENZ 600 MG TABLET?
Since Oct 14, 2020, the NADAC for EFAVIRENZ 600 MG TABLET has ranged from a low of $1.3206 (Feb 19, 2025) to a high of $9.0741 (Dec 16, 2020), with a median of $2.7606 per EA.
Are there cheaper alternatives to EFAVIRENZ 600 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EFAVIRENZ 600 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures EFAVIRENZ 600 MG TABLET?
EFAVIRENZ 600 MG TABLET (NDC 65862004930) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.